Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults.

Kitamura A, Seino S, Abe T, Nofuji Y, Yokoyama Y, Amano H, Nishi M, Taniguchi Y, Narita M, Fujiwara Y, Shinkai S. · 2021

Read Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. by Kitamura A, Seino S, Abe T, Nofuji Y, Yokoyama Y, Amano H, Nishi M, Taniguchi Y, Narita M, Fujiwara Y, Shinkai S. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7890144.txt.

Introduction

Kitamura and co-authors report a cohort study of sarcopenia in older adults in Japan. Sarcopenia is the loss of muscle mass and strength that comes with age. Evidence on it in Asian populations has been limited. The team measured its frequency and its link to death and disability.

They followed 1851 community-dwelling residents aged 65 years or older for 5.8 years. Sarcopenia was found in 11.5% of men and 16.7% of women. Low blood albumin, weak cognition, low activity, and recent hospital stays were tied to the condition in men. People with sarcopenia faced higher risks of both death and new disability. Muscle loss paired with weakness carried the clearest risk. The study gives Asian health services firm local numbers for planning care.

Catalog record

CREATORKitamura A, Seino S, Abe T, Nofuji Y, Yokoyama Y, Amano H, Nishi M, Taniguchi Y, Narita M, Fujiwara Y, Shinkai S.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7890144

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults By Akihiko Kitamura, Satoshi Seino, Takumi Abe, Yu Nofuji, Yuri Yokoyama, Hidenori Amano, Mariko Nishi, Yu Taniguchi, Miki Narita, Yoshinori Fujiwara, Shoji Shinkai Published in: Journal of Cachexia, Sarcopenia and Muscle DOI: 10.1002/jcsm.12651 ABSTRACT Abstract Background There is limited evidence on sarcopenia in Asian populations. This study aimed to clarify the prevalence, associated factors, and the magnitude of association with mortality and incident disability for sarcopenia and combinations of its components among Japanese community‐dwelling older adults. Methods We conducted a 5.8 year prospective study of 1851 Japanese residents aged 65 years or older (50.5% women; mean age 72.0 ± 5.9) who participated in health check‐ups. Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 algorithm. Appendicular lean mass index (ALMI) was measured using direct segmental multi‐frequency bioelectrical impedance analysis. A Cox proportional hazards regression model was used to identify associations of sarcopenia and the combinations of its components with all‐cause mortality and incident disability. Results The prevalence of sarcopenia was 11.5% (105/917) in men and 16.7% (156/934) in women. Significant sarcopenia‐related factors other than ageing were hypoalbuminaemia, cognitive impairment, low activity, and recent hospitalization (all P‐values <0.05) among men and cognitive impairment (P = 0.004) and depressed mood (P < 0.001) among women. Individuals with sarcopenia had higher risks of mortality [hazard ratios (95% confidence interval): 2.0 (1.2–3.5) in men and 2.3 (1.1–4.9) in women] and incident disability [1.6 (1.0–2.7) in men and 1.7 (1.1–2.7) in women]. Compared with the individuals without any sarcopenia components, those having low grip strength and/or slow gait speed without low ALMI tended to have an increased risk of disability [1.4 (1.0–2.0), P = 0.087], but not mortality [1.3 (0.8–2.2)]. We did not find increased risks of these outcomes in participants having low ALMI in the absence of low grip strength and slow gait speed [1.2 (0.8–1.9) for mortality and 0.9 (0.6–1.3) for incident disability]. Conclusions Japanese older men and women meeting Asian criteria of sarcopenia had increased risks of all‐cause mortality and disability. There were no significant increased risks of death or incident disability for both participants with muscle weakness and/or low performance without low muscle mass and those with low muscle mass with neither muscle weakness nor low performance. Further studies are needed to examine the interaction between muscle loss, muscle weakness, and low performance for adverse health‐related outcomes. Keywords: Community‐based sample, Prospective study, Appendicular lean mass index, Handgrip strength, Gait speed INTRODUCTION Sarcopenia is a progressive skeletal muscle disorder that is associated with an increased risk of adverse outcomes including frailty, physical disability, and mortality. Several meta‐analyses of observational studies reported approximately two‐fold to four‐fold higher risk of mortality and functional disability irrespective of differences in the measurement and criteria of sarcopenia. 1 , 2 , 3 According to these meta‐analyses, most previous studies on the relative risks of death and disability in community‐dwelling older adults with sarcopenia have been conducted in Europe and the USA. There have been only a few studies 4 , 5 , 6 with Asian populations, whose body composition, muscle strength, and physical performance are different from those of Western populations. Furthermore, there is limited evidence on sex differences in the effects of sarcopenia on mortality or disability, even in Western countries. 7 Regarding sarcopenia components, although the specific associations of muscle mass, muscle strength, and physical performance with adverse health‐related outcomes have been documented, 8 , 9 , 10 , 11 , 12 , 13 the effect of their combinations on clinical consequences has not been well examined. In 2018, the European Working Group on Sarcopenia in Older People (EWGSOP) updated the original definition to reflect growing evidence regarding this condition over the last decade, 14 followed by revised sarcopenia criteria submitted by the Asian Working Group for Sarcopenia in 2019 (AWGS 2019). 15 The algorithms of sarcopenia by EWGSOP2 and AWGS 2019 included low muscle mass as an essential factor in defining sarcopenia, and thus, individuals who do not have low muscle mass are categorized as non‐sarcopenia, regardless of muscle weakness or low performance. However, the recent definition of sarcopenia by the Sarcopenia Definition and Outcomes Consortium has included both muscle weakness and slowness, but not low lean mass. 16 Therefore, the impact of the association of lower levels of muscle strength or physical performance with and without low muscle mass on the risk of adverse health‐related outcomes should be further examined to develop an evidence‐based definition of sarcopenia. The aim of the present study was to investigate the prevalence, associated factors, and magnitude of association with mortality and incident disability for sarcopenia and the combinations of its components among Japanese community‐dwelling older men and women. METHODS Study cohort The study cohort comprised residents aged 65 years or older who participated in annual health check‐ups between 2008 and 2016 in Kusatsu, a Japanese town in Gunma Prefecture, 17 and biennial health check‐ups between 2010 and 2014 in Hatoyama, a town in Saitama Prefecture 18 in Japan. Baseline data for this study were on 1950 participants (1254 in Kusatsu and 696 in Hatoyama) who completed an assessment for sarcopenia at an initial check‐up during the study period. Participants who had missing data were excluded (n = 99); consequently, this study included 1851 participants (50.5% women; mean age 72.0 ± 5.9). Written informed consent was obtained from all participants after they were provided with a detailed explanation of the study protocol, which was developed in accordance with the guidelines proposed in the Declaration of Helsinki and was approved by the Ethics Committee of the Tokyo Metropolitan Institute of Gerontology. Definition of sarcopenia Sarcopenia was assessed based on the AWGS 2019 criteria, which are composed of three components: appendicular lean mass, grip strength, and physical function measures. 16 Appendicular lean mass was measured using direct segmental multi‐frequency bioelectrical impedance analysis (BIA) (InBody 720 analyser, InBody Co., Ltd., Seoul, Korea). 19 We calculated appendicular lean soft tissue mass (LSTM) from the estimate of LSTM of arms and legs; then, the appendicular lean mass index (ALMI) was calculated by dividing appendicular LSTM by height in m2. As evaluated by BIA, the ALMI cut‐off point for sarcopenia was <7.0 kg/m2 for men and <5.7 kg/m2 for women. We also determined body mass index (BMI), fat‐free mass index (FFMI), and fat mass index (FMI). Handgrip strength (kg) was measured twice in the dominant hand, with the participant squeezing a Smedley‐type handgrip dynamometer (Yagami Co, Tokyo, Japan) as hard as possible; the higher of the two measurements was used in the analysis. The definitions of low grip strength for men and women were <28 and <18 kg, respectively. Gait speed was measured over a straight 11 m walkway marked with tape at 3 and 8 m. Well‐trained observers, using a stopwatch, gauged the time required to walk 5 m at a natural speed and calculated usual gait speed (m/s). The lower level of physical function was evaluated by usual gait speed and defined as <1.0 m/s for both sexes. According to the procedure proposed by the AWGS 2019, 15 sarcopenia was defined as occurring when participants had low ALMI and low grip strength and/or slow

Read the complete text